|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07D 263/57 | |
| A61K 31/423 | |||
| A61P 25/00 |
| (11) | Patento numeris | 3453703 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 17792508.8 |
| Europos patento paraiškos padavimo data | 2017-05-05 | |
| (97) | Europos patento paraiškos paskelbimo data | 2019-03-13 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-06-24 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/CN2017/083177 |
| Data | 2017-05-05 |
| (87) | Numeris | WO 2017/190682 |
| Data | 2017-11-09 |
| (30) | Numeris | Data | Šalis |
| 201610293338 | 2016-05-05 | CN |
| (72) |
CHEN, Minhua, CN
ZHANG, Yanfeng, CN
LI, Jiaoyang, CN
ZHANG, Xiaoyu, CN
|
| (73) |
Crystal Pharmatech Co., Ltd,
B4-101 Biobay 218 Xinghu Street Suzhou Industrial Park, Suzhou, Jiangsu 215123,
CN
|
| (54) | CRYSTALLINE FORM E OF TAFAMIDIS MEGLUMINE, PROCESS FOR PREPARATION AND USE THEREOF |
| CRYSTALLINE FORM E OF TAFAMIDIS MEGLUMINE, PROCESS FOR PREPARATION AND USE THEREOF |